GRAIL's Galleri test for early cancer detection receives positive feedback from the FDA Advisory Committee, signaling a significant step forward in cancer screening.

Linus Health's digital cognitive assessments have surpassed new benchmarks for early cognitive impairment detection, enhancing diagnostic workflows significantly.

The Tokyo Health Walk 2025 aims to raise awareness of colorectal cancer with walking events and free screenings for participants aged 40 and older. Join us!

A groundbreaking study led by Genomics England and NHS England has identified two brothers with a genetic mutation linked to adrenoleukodystrophy (ALD), a progressive neurological disorder affecting vision, movement, and adrenal glands. The Generation Study screens 100,000 newborns using whole genome sequencing to detect over 200 rare genetic conditions before symptoms manifest. Early diagnosis allows the eight-month-old and four-year-old brothers to undergo regular scans and blood tests, enabling timely medical intervention. ALD is typically difficult to treat once physical symptoms develop, making early detection critical. Over 85,000 families have joined the study, which aims to revolutionize NHS genetic screening. The case highlights how maternal participation in prenatal trials can uncover rare conditions, offering hope for proactive healthcare. This research underscores the potential of genomic technology to transform medical diagnostics and improve patient outcomes through preventative care.

Stand Up To Cancer announces funding for projects aimed at creating noninvasive tests for early lung cancer detection, addressing urgent medical needs.

Recent advancements in AI technology have shown promising potential in identifying early indicators of breast cancer, potentially six years prior to diagnosis, according to a new study.

The Diabetes Leadership Council emphasizes the necessity of early detection of Type 1 Diabetes through improved screening in primary care, which can enhance patient outcomes.

CancerCheck introduces a groundbreaking blood test for early detection of cancer, utilizing advanced technology to improve survival rates significantly.

Alamar Biosciences has successfully closed an oversubscribed convertible note financing and announced significant leadership team expansions to support its growth.

Eon has appointed Tammy Lewis as Chief Commercial Officer, aiming to boost the adoption of its AI-driven platform for early detection in healthcare.

Cancer Check Labs has expanded its innovative multi-cancer early detection test into New York, aiming to enhance cancer screening accessibility statewide.

The Karmanos Cancer Institute promotes Lung Cancer Awareness Month, urging smokers to seek screenings for early detection and treatment options.

The global cancer diagnostics market is poised for significant growth, expected to reach USD 215 billion by 2035, driven by rising cancer rates and advancements in technology.

Recent studies reveal the potential of AI in early type 1 diabetes detection, identifying risks before symptoms manifest. This advancement could prompt timely intervention and improve patient outcomes.

Join the 2nd Annual Men's Health Screening & Prostate Cancer Expo in Madison on May 17, 2025, for free screenings and expert discussions on prostate cancer awareness.

A recent report by the Alzheimer's Association reveals that most Americans prioritize early diagnosis and treatment, even if it involves risks. The findings highlight growing awareness and willingness to face Alzheimer's disease head-on.

GRAIL, Inc. has announced the grant of equity awards as an inducement for new employees, reinforcing its commitment to early cancer detection.

This Giving Tuesday, the American Cancer Fund launches an initiative focused on promoting early cancer detection. Support today!